Data / Form D filings / CalciMedica Subsidiary, Inc.
CalciMedica Subsidiary, Inc.: Form D filings
CalciMedica Subsidiary, Inc., a biotechnology company in La Jolla, CA, filed 10 Form D notices with the SEC between 2009 and 2023. The latest, on April 4, 2023, reports $10.3 million sold of a $10.3 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 505 COAST BOULEVARD SOUTH, SUITE 307, La Jolla, CA, 92037
- Phone
- (858) 952-5500
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1385359
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 4, 2023 | New notice | $10,340,663 | $10,340,663 | 8 | Mar 20, 2023 | sec.gov | |
| May 27, 2020 | New notice | $17,194,272 | $17,194,272 | 12 | May 20, 2020 | sec.gov | |
| Apr 24, 2014 | New notice | $13,090,000 | $2,499,999 | $10,590,001 | 5 | Apr 11, 2014 | sec.gov |
| Jul 15, 2013 | New notice | $9,000,000 | $3,000,000 | $6,000,000 | 3 | Jul 1, 2013 | sec.gov |
| Nov 5, 2012 | New notice | $4,600,000 | $4,600,000 | 3 | Oct 25, 2012 | sec.gov | |
| Apr 2, 2012 | New notice | $13,200,000 | $13,200,000 | 3 | Mar 20, 2012 | sec.gov | |
| Sep 29, 2011 | New notice | $4,000,000 | $4,000,000 | 3 | Sep 19, 2011 | sec.gov | |
| Feb 8, 2011 | Amendment | $9,163,636 | $9,163,636 | 6 | Jul 15, 2010 | sec.gov | |
| Jul 22, 2010 | New notice | $9,000,000 | $3,000,000 | $6,000,000 | 5 | Jul 15, 2010 | sec.gov |
| Nov 6, 2009 | New notice | $12,000,000 | $9,000,000 | $3,000,000 | 3 | Oct 28, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kenneth A. Stauderman | Executive Officer | |
| A. Rachel Leheny | Executive Officer, Director | |
| Daniel J. Geffken | Executive Officer | |
| Sudarshan J. Hebbar | Executive Officer | |
| Eric W. Roberts | Executive Officer | |
| Michael J. Dunn | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Apr 3, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CalciMedica Subsidiary, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.